These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38286559)

  • 1. A chemo/chemodynamic nanoparticle based on hyaluronic acid induces ferroptosis and apoptosis for triple-negative breast cancer therapy.
    Wang N; Zhang Q; Wang Z; Liu Y; Yang S; Zhao X; Peng J
    Carbohydr Polym; 2024 Apr; 329():121795. PubMed ID: 38286559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeted delivery of hyaluronic acid/polydopamine-coated Fe
    Liang KA; Chih HY; Liu IJ; Yeh NT; Hsu TC; Chin HY; Tzang BS; Chiang WH
    J Colloid Interface Sci; 2025 Jan; 677(Pt A):400-415. PubMed ID: 39096708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
    Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
    Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
    Wang S; Zhang J; Wang Y; Chen M
    Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin-Coated Metal-Phenolic Networks for Cooperative Tumor Chemo-/Chemodynamic/Immune Therapy via Enhanced Ferroptosis-Mediated Immunogenic Cell Death.
    Xu Y; Guo Y; Zhang C; Zhan M; Jia L; Song S; Jiang C; Shen M; Shi X
    ACS Nano; 2022 Jan; 16(1):984-996. PubMed ID: 35023715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Sr/Se co-doped ZIF-8 nanozyme for chemo/chemodynamic synergistic tumor therapy
    Wu A; Han M; Ni Z; Li H; Chen Y; Yang Z; Feng Y; He Z; Zhen H; Wang X
    Theranostics; 2024; 14(5):1939-1955. PubMed ID: 38505601
    [No Abstract]   [Full Text] [Related]  

  • 9. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
    Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
    Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
    Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
    J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
    Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma.
    Shetake NG; Das SK; Kumar A; Pandey BN
    Biomater Adv; 2024 Jul; 161():213868. PubMed ID: 38677038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
    Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
    Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and evaluation of a nanosystem that combines acidification promoted chemodynamic therapy and intracellular drug release monitoring.
    Dong K; Wang D; Lin L; Niu P; Wang Y; Tan Q; Xing J
    J Biotechnol; 2024 Mar; 383():13-26. PubMed ID: 38325656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIR Responsive Doxorubicin-Loaded Hollow Copper Ferrite @ Polydopamine for Synergistic Chemodynamic/Photothermal/Chemo-Therapy.
    Chu X; Zhang L; Li Y; He Y; Zhang Y; Du C
    Small; 2023 Feb; 19(7):e2205414. PubMed ID: 36504423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-Loaded Liposomes Tagged with Hyaluronic Acid Have Synergistic Effects in Triple-Negative Breast Cancer.
    Dong S; Bi Y; Sun X; Zhao Y; Sun R; Hao F; Sun Y; Wang Y; Li X; Deng W; Liu X; Ha J; Teng L; Gong P; Xie J; Kim BYS; Yang Z; Jiang W; Teng L
    Small; 2022 Apr; 18(16):e2107690. PubMed ID: 35277914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, Biosafety, and Cytotoxicity Studies of a Newly Tumor-Microenvironment-Responsive Biodegradable Mesoporous Silica Nanosystem Based on Multimodal and Synergistic Treatment.
    He Z; Zhang H; Li H; Wang Y; Qian J; Cai X; Sun L; Huang J
    Oxid Med Cell Longev; 2020; 2020():7152173. PubMed ID: 33488930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell.
    Kang Z; Yang M; Feng X; Liao H; Zhang Z; Du Y
    Int J Nanomedicine; 2022; 17():2165-2187. PubMed ID: 35592098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrastigma hemsleyanum polysaccharide combined with doxorubicin promote ferroptosis and immune function in triple-negative breast cancer.
    Shang Y; Zhao M; Chen S; Chen Y; Liu X; Zhou F; Li Y; Long M; Xu K; Ding Z; Wang L
    Int J Biol Macromol; 2024 Aug; 275(Pt 1):133424. PubMed ID: 38945330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
    Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
    Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.